Description: Y.S.P. Southeast Asia Holding Berhad, an investment holding company, operates as a pharmaceutical company. It provides prescription products comprising antiasthmatic, antihistamine, and adjuvant therapy products; antibacterial and analgesic lozenges, antibiotics, antidiarrheals, antiemetics, antiprotozoal and antiamoebics, antispasmodics, antispasmodics with psycholeptics, drugs used in BPH, drugs for gout therapy, H2-antagonists, hypnotics and sedatives, antifibrinolytics, nootropics and neurotonics, non-steroidal anti-inflammatory, antipyretics and analgesics, peripheral vasodilators, proton pump inhibitors, skeletal muscle relaxants, anesthesia, anxiolytics, and topical corticosteroids and keratolytics; antidiabetic, antifungal, lipid regulating, antihypertensive, antitussive, antiviral, and ovulation inductive agents; and steroidal, anorectal, topical, and ophthamological preparations. The company also offers non-prescription products, such as anthelmintic agents, antacids, antiinflammatory and digestive enzymes, antipyretics and analgesics, antiplatelet, carminatives, expectorants/mucolytic agents, haemorrhoidal and topical preparations, and laxatives; and traditional medicines. In addition, it provides veterinary pharmaceutical products for aquatic and livestock, including anthelmintics, antibiotics, anticoccidial and drying agent, antifungals, antipyretics and analgesics, disinfectants/antiseptic, electrolytes, enzyme and hormone preparations, hematopoietic nutrients, herbal extracts, vitamins and minerals supplements, antimicrobials, immune?enhancer, larval feeds, and probiotics/water treatment remedy. Further, it offers disposables, medical devices, test kits, medical aids, insect repellents; cosmetics, fine chemicals, and health food products; and management services. It operates in Malaysia, Singapore, the Philippines, Vietnam, Cambodia, Myanmar, Brunei, and other countries. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.
Exchange: KLSE
Country: MY
Currency: Malaysian Ringgit (RM)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 13.2787 |
| Price-to-Book MRQ: | 0.9711 |
| Price-to-Sales TTM: | 1.0902 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |